M. Soty, A. Gautier-stein, F. Rajas, and G. Mithieux, Gut-Brain Glucose Signaling in Energy Homeostasis, Cell Metab, vol.25, issue.6, pp.1231-1242, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02339600

J. E. Gerich, C. Meyer, H. J. Woerle, and M. Stumvoll, Renal gluconeogenesis: its importance in human glucose homeostasis, Diabetes Care, vol.24, issue.2, pp.382-391, 2001.

C. Meyer, J. M. Dostou, S. L. Welle, and J. E. Gerich, Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis, Am J Physiol Endocrinol Metab, vol.282, issue.2, pp.419-427, 2002.

B. Pillot, M. Soty, A. Gautier-stein, C. Zitoun, and G. Mithieux, Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin, Endocrinology, vol.150, issue.2, pp.616-624, 2009.

G. Mithieux, I. Bady, A. Gautier, M. Croset, F. Rajas et al., Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes, Am J Physiol Endocrinol Metab, vol.286, issue.3, pp.370-375, 2004.

A. Penhoat, L. Fayard, A. Stefanutti, G. Mithieux, and F. Rajas, Intestinal gluconeogenesis is crucial to maintain a physiological fasting glycemia in the absence of hepatic glucose production in mice, Metabolism, vol.63, issue.1, pp.104-111, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01859366

B. L. Wajchenberg, ?-Cell Failure in Diabetes and Preservation by Clinical Treatment, Endocr Rev, vol.28, issue.2, pp.187-218, 2007.

G. C. Weir and S. Bonner-weir, Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes, Diabetes, vol.53, pp.16-21, 2004.

L. Chen, D. J. Magliano, and Z. Pz, The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives, Nat Rev Endocrinol, vol.8, issue.4, pp.228-236, 2012.

H. V. Lin and A. D. , Hormonal regulation of hepatic glucose production in health and disease, Cell Metab, vol.14, issue.1, pp.9-19, 2011.

J. M. Hazlehurst, C. Woods, T. Marjot, J. F. Cobbold, and J. W. Tomlinson, Non-alcoholic fatty liver disease and diabetes, Metabolism, vol.65, issue.8, pp.1096-1108, 2016.

R. M. Williamson, J. F. Price, S. Glancy, E. Perry, L. D. Nee et al., Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study, Diabetes Study Investigators, vol.34, issue.2, pp.1139-1144, 2011.

H. Watanabe, Y. Inaba, K. Kimura, M. Matsumoto, S. Kaneko et al., Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein, Nat Commun, vol.9, issue.1, p.30, 2018.

J. Schwarz, P. Linfoot, D. Dare, and K. Aghajanian, Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, highcarbohydrate isoenergetic diets, Am J Clin Nutr, vol.77, issue.1, pp.43-50, 2003.

A. Abdul-wahed, S. Guilmeau, and C. Postic, Sweet Sixteenth for ChREBP: Established Roles and Future Goals, Cell Metab, vol.26, issue.2, pp.324-341, 2017.

J. D. Browning and J. D. Horton, Molecular mediators of hepatic steatosis and liver injury, J Clin Invest, vol.114, issue.2, pp.147-152, 2004.

Y. Wang, J. Viscarra, and S. Kim, Transcriptional regulation of hepatic lipogenesis, Nat Rev Mol Cell Biol, vol.16, issue.11, pp.678-689, 2015.

C. Postic and J. Girard, Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, J Clin Invest, vol.118, issue.3, pp.829-838, 2008.

P. S. Kishnani, S. L. Austin, J. E. Abdenur, P. Arn, D. S. Bali et al., Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics, Genet Med Off J Am Coll Med Genet, vol.16, issue.11, p.1, 2014.

N. Bruni, F. Rajas, S. Montano, F. Chevalier-porst, M. I. Mithieux et al., Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a, Ann Hum Genet, vol.63, issue.2, pp.358-360, 1996.

R. Bandsma, G. Smit, and F. Kuipers, Disturbed lipid metabolism in glycogen storage disease type 1, Eur J Pediatr, vol.161, issue.1, pp.65-69, 2014.

B. Sun, S. Li, L. Yang, T. Damodaran, D. Desai et al., Activation of glycolysis and apoptosis in glycogen storage disease type Ia, Mol Genet Metab, vol.97, issue.4, pp.267-271, 2009.

R. Bandsma, B. H. Prinsen, M. De-sain-van-der-velden, J. Rake, T. Boer et al., Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a, Pediatr Res, vol.63, issue.6, pp.702-707, 2008.

F. Rajas, H. Jourdan-pineau, A. Stefanutti, E. A. Mrad, P. B. Iynedjian et al., Immunocytochemical localization of glucose 6-phosphatase and cytosolic phosphoenolpyruvate carboxykinase in gluconeogenic tissues reveals unsuspected metabolic zonation, Histochem Cell Biol, vol.127, issue.5, pp.555-565, 2007.

, Cell Stress, vol.3, issue.3, 2019.

M. Gjorgjieva, M. H. Oosterveer, G. Mithieux, and F. Rajas, Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment, J Inborn Errors Metab Screen, vol.4, p.2326409816679429, 2016.

M. Gjorgjieva, J. Calderaro, L. Monteillet, M. Silva, M. Raffin et al., Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia, J Hepatol, vol.69, issue.5, pp.1074-1087, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02339527

J. Cho, G. Kim, B. C. Mansfield, and J. Y. Chou, Hepatic glucose-6-phosphatase-? deficiency leads to metabolic reprogramming in glycogen storage disease type Ia, Biochem Biophys Res Commun, vol.498, issue.4, pp.925-931, 2018.

F. Rajas, P. Labrune, and G. Mithieux, Glycogen storage disease type 1 and diabetes: learning by comparing and contrasting the two disorders, Diabetes Metab, vol.39, issue.5, pp.377-387, 2013.

M. Gargouri, C. Magné, E. Feki, and A. , Hyperglycemia, oxidative stress, liver damage and dysfunction in alloxan-induced diabetic rat are prevented by Spirulina supplementation, Nutr Res, vol.36, issue.11, pp.1255-1268, 2016.

P. Manna, J. Das, J. Ghosh, and P. C. Sil, Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondriadependent pathways: Prophylactic role of arjunolic acid, Free Radic Biol Med, vol.48, issue.11, pp.1465-1484, 2010.

N. U. Ashraf and T. A. Sheikh, Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease, Free Radic Res, vol.49, issue.12, pp.1405-1418, 2015.

S. Spahis, E. Delvin, J. Borys, and L. E. , Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis, 2017.

, Antioxid Redox Signal, vol.26, issue.10, pp.519-541

J. M. Forbes and C. Me, Mechanisms of diabetic complications, Physiol Rev, vol.93, issue.1, pp.137-188, 2013.

X. Chen, W. Wu, Q. Zhou, J. Jie, C. X. Wang et al., Advanced glycation end-products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEs under diabetic conditions, J Cell Biochem, vol.120, issue.2, pp.2159-2170, 2018.

G. Filomeni, D. Zio, D. Cecconi, and F. , Oxidative stress and autophagy: the clash between damage and metabolic needs, Cell Death Differ, vol.22, issue.3, pp.377-388, 2015.

S. Satapati, B. Kucejova, J. Duarte, J. A. Fletcher, L. Reynolds et al., Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver, J Clin Invest, vol.125, issue.12, pp.4447-4462, 2015.

N. E. Sunny, F. Bril, and K. Cusi, Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies, Trends Endocrinol Metab TEM, vol.28, issue.4, pp.250-260, 2017.

M. Lorenzi, The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient, Exp Diabetes Res, p.61038, 2007.

A. P. Rolo and C. M. Palmeira, Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress, Toxicol Appl Pharmacol, vol.212, issue.2, pp.167-178, 2006.

H. Vlassara and G. E. Striker, AGE restriction in diabetes mellitus: a paradigm shift, Nat Rev Endocrinol, vol.7, issue.9, pp.526-539, 2011.

S. Horiuchi, The liver is the main site for metabolism of circulating advanced glycation end products, J Hepatol, vol.36, issue.1, pp.123-125, 2002.

N. Ahmed, Advanced glycation endproducts--role in pathology of diabetic complications, Diabetes Res Clin Pract, vol.67, issue.1, pp.3-21, 2005.

M. G. Buse, Hexosamines, insulin resistance and the complications of diabetes: current status, Am J Physiol Endocrinol Metab, vol.290, issue.1, pp.1-8, 2006.

E. D. Schleicher and C. Weigert, Role of the hexosamine biosynthetic pathway in diabetic nephropathy, Kidney Int Suppl, vol.77, pp.1-13, 2000.

R. K. Sindhu, J. Koo, C. K. Roberts, and N. D. Vaziri, Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies, Clin Exp Hypertens, vol.26, issue.1, pp.43-53, 2004.

T. Lao-ong, W. Chatuphonprasert, N. Nemoto, and K. Jarukamjorn, Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine, Pharm Biol, vol.50, issue.8, pp.1007-1012, 2012.

M. Fedorova, R. C. Bollineni, and R. Hoffmann, Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies, Mass Spectrom Rev, vol.33, issue.2, pp.79-97, 2014.

N. R. Jena, DNA damage by reactive species: Mechanisms, mutation and repair, J Biosci, vol.37, issue.3, pp.503-517, 2012.

S. C. Lee and J. C. Chan, Evidence for DNA Damage as a Biological Link Between Diabetes and Cancer, Chin Med J, vol.128, issue.11, pp.1543-1548, 2015.

A. I. Schmid, J. Szendroedi, M. Chmelik, M. Kr??ák, E. Moser et al., Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes, Diabetes Care, vol.34, issue.2, pp.448-453, 2011.

M. Jain, S. Ngoy, S. A. Sheth, R. A. Swanson, E. P. Rhee et al., A systematic survey of lipids across mouse tissues, Am J Physiol-Endocrinol Metab, vol.306, issue.8, 2014.

A. S. Greenberg, J. J. Egan, S. A. Wek, N. B. Garty, E. J. Blanchette-mackie et al., Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets, J Biol Chem, vol.266, issue.17, pp.11341-11346, 1991.

N. L. Gluchowski, M. Becuwe, T. C. Walther, and F. Rv, , 2017.

, Lipid droplets and liver disease: from basic biology to clinical implications, Nat Rev Gastroenterol Hepatol, vol.14, issue.6, pp.343-355

K. Yamaguchi, L. Yang, S. Mccall, J. Huang, X. X. Yu et al., Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatol Baltim Md, vol.45, issue.6, pp.1366-1374, 2007.

N. Alkhouri, L. J. Dixon, and A. E. Feldstein, Lipotoxicity in Nonalcoholic Fatty Liver Disease: Not All Lipids Are Created Equal, Expert Rev Gastroenterol Hepatol, vol.3, issue.4, pp.445-451, 2009.

, Cell Stress, vol.3, issue.3, 2019.

S. Pelusi and L. Valenti, Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease, Liver Int, 2018.

D. M. Erion and G. I. Shulman, Diacylglycerol-mediated insulin resistance, Nat Med, vol.16, issue.4, pp.400-402, 2010.

S. Galadari, A. Rahman, S. Pallichankandy, and A. Galadari, Role of ceramide in diabetes mellitus: evidence and mechanisms, Lipids Health Dis, vol.12, p.98, 2013.

M. D. Weltman, G. C. Farrell, P. Hall, M. Ingelman-sundberg, and C. Liddle, Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis, Hepatol Baltim Md, vol.27, issue.1, pp.128-133, 1998.

K. Linhart, H. Bartsch, and H. K. Seitz, The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts, Redox Biol, vol.3, pp.56-62, 2014.

S. Fu, L. Yang, P. Li, O. Hofmann, L. Dicker et al., Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity, Nature, vol.473, issue.7348, pp.528-531, 2011.

C. Zhang, X. Lu, Y. Tan, B. Li, X. Miao et al., Diabetes-Induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model, PLoS ONE, vol.7, issue.12, 2012.

J. Han and R. J. Kaufman, The role of ER stress in lipid metabolism and lipotoxicity, J Lipid Res, vol.57, issue.8, pp.1329-1338, 2016.

P. Ferré and F. Foufelle, Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c, Cicho?-Lach H, and Michalak A, vol.12, pp.8082-8091, 2010.

J. Mohamed, N. Nafizah, A. H. Zariyantey, A. H. , and B. Sb, Mechanisms of Diabetes-Induced Liver Damage. Sultan Qaboos, Univ Med J, vol.16, issue.2, pp.132-141, 2016.

I. A. Leclercq, A. Morais, B. Schroyen, N. V. Hul, and A. Geerts, Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences, J Hepatol, vol.47, issue.1, pp.142-156, 2007.

M. Banerjee and M. Saxena, Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes, Clin Chim Acta Int J Clin Chem, vol.413, pp.1163-1170, 2012.

P. I. Ingaramo, M. T. Ronco, D. Francés, J. A. Monti, G. B. Pisani et al., Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus, Mol Immunol, vol.48, pp.1397-1407, 2011.

D. E. Francés, P. I. Ingaramo, M. T. Ronco, and C. Ce, , 2013.

, an inflammatory process: Oxidative Stress and TNF-alpha involved in hepatic complication, J Biomed Sci Eng, vol.06, issue.06, p.645

P. J. Klover, T. A. Zimmers, L. G. Koniaris, and R. A. Mooney, Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice, Diabetes, vol.52, issue.11, pp.2784-2789, 2003.

D. Schmidt-arras, R. , and S. , IL-6 pathway in the liver: From physiopathology to therapy, J Hepatol, vol.64, issue.6, pp.1403-1415, 2016.

F. T. Wunderlich, P. Ströhle, A. C. Könner, S. Gruber, S. Tovar et al., Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action, Cell Metab, vol.12, issue.3, pp.237-249, 2010.

B. Gao and H. Tsukamoto, Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?, Gastroenterology, vol.150, issue.8, pp.1704-1709, 2016.

V. L. Gadd, R. Skoien, E. E. Powell, K. J. Fagan, C. Winterford et al., The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease, Hepatol Baltim Md, vol.59, issue.4, pp.1393-1405, 2014.

C. Ma, A. H. Kesarwala, T. Eggert, J. Medina-echeverz, D. E. Kleiner et al., NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis, Nature, vol.531, issue.7593, pp.253-257, 2016.

T. L. Archuleta, A. M. Lemieux, V. Saengsirisuwan, M. K. Teachey, K. A. Lindborg et al., Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK, Free Radic Biol Med, vol.47, issue.10, pp.1486-1493, 2009.

A. Rossi, M. Ruoppolo, P. Formisano, G. Villani, L. Albano et al., Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?, J Inherit Metab Dis, 2018.

K. J. Lei, H. Chen, C. J. Pan, J. M. Ward, B. Mosinger et al., Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse, Nat Genet, vol.13, issue.2, pp.203-209, 1996.

E. Mutel, A. Abdul-wahed, N. Ramamonjisoa, A. Stefanutti, I. Houberdon et al., Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J Hepatol, vol.54, issue.3, pp.529-537, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00575314

E. Mutel, A. Gautier-stein, A. Abdul-wahed, M. Amigó-correig, C. Zitoun et al., Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice, Diabetes, vol.60, issue.12, pp.3121-3131, 2011.

B. L. Farah, R. A. Sinha, Y. Wu, B. K. Singh, A. Lim et al., Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa), Sci Rep, vol.7, p.44408, 2017.

J. Cho, G. Kim, B. C. Mansfield, and J. Y. Chou, Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia, J Inherit Metab Dis, 2018.

B. Wittenstein, M. Klein, B. Finckh, K. Ullrich, and A. Kohlschütter, Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia, Free Radic Biol Med, vol.33, issue.1, pp.103-110, 2002.

K. Ucar, S. Coker, M. Sözmen, E. , G. Simsek et al., A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III, Nutr Metab Cardiovasc Dis, vol.19, issue.6, pp.383-390, 2009.

E. Koren, J. Lipkin, A. Klar, E. Hershkovitz, I. Ginsburg et al., Total oxidant-scavenging capacities of plasma from glycogen storage disease type Ia patients as measured by cyclic voltammetry, FRAP and luminescence techniques, J Inherit Metab Dis, vol.32, issue.5, p.651, 2009.

Y. Y. Sautin and J. Rj, URIC ACID: THE OXIDANT-ANTIOXIDANT PARADOX, Nucleosides Nucleotides Nucleic Acids, vol.27, issue.6, pp.608-619, 2008.

A. Abdul-wahed, A. Gautier-stein, S. Casteras, M. Soty, D. Roussel et al., A link between hepatic glucose production and peripheral energy metabolism via hepatokines, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01350728

, Mol Metab, vol.3, issue.5, pp.531-543

L. Monteillet, M. Gjorgjieva, M. Silva, V. Verzieux, L. Imikirene et al., Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context, Mol Metab, vol.16, pp.100-115, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02339561

B. L. Farah, D. J. Landau, R. A. Sinha, E. D. Brooks, Y. Wu et al., Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency, J Hepatol, vol.64, issue.2, pp.370-379, 2016.

J. Cho, G. Kim, C. Pan, J. Anduaga, E. Choi et al., Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia, PLOS Genet, vol.13, issue.5, p.1006819, 2017.

R. Mathew, V. Karantza-wadsworth, and E. White, Role of autophagy in cancer, Nat Rev Cancer, vol.7, issue.12, pp.961-967, 2007.

G. Kroemer, G. Mariño, and B. Levine, Autophagy and the integrated stress response, Mol Cell, vol.40, issue.2, pp.280-293, 2010.

S. Namkoong, C. Cho, I. Semple, and J. H. Lee, Autophagy Dysregulation and Obesity-Associated Pathologies, Mol Cells, vol.41, issue.1, pp.3-10, 2018.

Q. Qian, Z. Zhang, A. Orwig, S. Chen, W. Ding et al., S-Nitrosoglutathione Reductase Dysfunction Contributes to Obesity-Associated Hepatic Insulin Resistance via Regulating Autophagy, Diabetes, vol.67, issue.2, pp.193-207, 2018.

V. J. Lavallard, Autophagy and non-alcoholic fatty liver disease, BioMed Res Int, p.120179, 2014.

S. Mei, H. Ni, S. Manley, A. Bockus, K. M. Kassel et al., Differential Roles of Unsaturated and Saturated Fatty Acids on Autophagy and Apoptosis in Hepatocytes, J Pharmacol Exp Ther, vol.339, issue.2, pp.487-498, 2011.

S. Y. Kim, D. A. Weinstein, M. F. Starost, B. C. Mansfield, and J. Y. Chou, Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia, J Hepatol, vol.48, issue.3, pp.479-485, 2008.

M. C. Blendea, M. J. Thompson, and S. Malkani, Diabetes and Chronic Liver Disease: Etiology and Pitfalls in Monitoring, Clin Diabetes, vol.28, issue.4, pp.139-144, 2010.

K. Fujita, H. Iwama, H. Miyoshi, J. Tani, K. Oura et al., Diabetes mellitus and metformin in hepatocellular carcinoma, World J Gastroenterol, vol.22, issue.27, pp.6100-6113, 2016.

P. Wang, D. Kang, W. Cao, Y. Wang, and Z. Liu, Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis, Diabetes Metab Res Rev, vol.28, issue.2, pp.109-122, 2012.

J. D. Yang, H. A. Mohamed, J. L. Cvinar, G. J. Gores, L. R. Roberts et al., Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis, Am J Gastroenterol, vol.111, issue.11, pp.1573-1580, 2016.

E. Giovannucci, D. M. Harlan, M. C. Archer, R. M. Bergenstal, S. M. Gapstur et al., Diabetes and cancer: a consensus report, CA Cancer J Clin, vol.60, issue.4, pp.207-221, 2010.

H. Chettouh, M. Lequoy, L. Fartoux, C. Vigouroux, D. et al., Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma, Liver Int Off J Int Assoc Study Liver, vol.35, issue.10, pp.2203-2217, 2015.

A. Chocarro-calvo, J. M. García-martínez, S. Ardila-gonzález, D. La-vieja, A. et al., Glucose-induced ?-catenin acetylation enhances Wnt signaling in cancer, Mol Cell, vol.49, issue.3, pp.474-486, 2013.

, The role of adipokines in liver fibrosis, Pathophysiol Off J Int Soc Pathophysiol, vol.15, issue.2, pp.91-101, 2008.

J. Crespo, A. Cayón, P. Fernández-gil, M. Hernández-guerra, M. Mayorga et al., Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients, Hepatol Baltim Md, vol.34, issue.6, pp.125-172, 2001.

P. Park, C. Sanz-garcia, and L. E. Nagy, Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver, Curr Pathobiol Rep, vol.3, issue.4, pp.243-252, 2015.

K. Jensen and C. Gluud, The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey), Hepatol Baltim Md, vol.20, pp.1061-1077, 1994.

D. Garcia-compean, J. O. Jaquez-quintana, J. A. Gonzalez-gonzalez, M. , and H. , Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management, World J Gastroenterol, vol.15, issue.3, pp.280-288, 2009.

P. Hsieh, J. Huang, O. N. Nfor, C. Lung, C. Ho et al., Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study, Oncotarget, vol.8, issue.46, pp.81321-81328, 2017.

G. Baffy, Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention, J Clin Transl Hepatol, vol.1, issue.2, pp.131-137, 2013.

C. Bertot, L. , and A. La, The Natural Course of Non-Alcoholic Fatty Liver Disease, Int J Mol Sci, vol.17, issue.5, 2016.

A. Sanyal, A. Poklepovic, E. Moyneur, and V. Barghout, Population-based risk factors and resource utilization for HCC: US perspective, Curr Med Res Opin, vol.26, issue.9, pp.2183-2191, 2010.

D. Q. Wang, L. M. Fiske, C. T. Carreras, and W. Da, NAT-URAL HISTORY OF HEPATOCELLULAR ADENOMA FORMATION IN GLY-COGEN STORAGE DISEASE TYPE I, J Pediatr, vol.159, issue.3, pp.442-446, 2011.

D. A. Rudnick and D. No, Functional Relationships between Lipid Metabolism and Liver Regeneration, Int J Hepatol, p.549241, 2012.

J. Huang, A. E. Schriefer, P. F. Cliften, D. Dietzen, S. Kulkarni et al., Postponing the Hypoglycemic Response to Partial Hepatectomy Delays Mouse Liver Regeneration, 2016.

, Am J Pathol, vol.186, issue.3, pp.587-599

M. Hole?ek, Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review, Nutrition, vol.15, issue.10, pp.784-788, 1999.

K. Miyanishi, T. Hoki, S. Tanaka, and J. Kato, Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy, World J Hepatol, vol.7, issue.3, pp.593-599, 2015.

A. Takaki and K. Yamamoto, Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?, World J Hepatol, vol.7, issue.7, pp.968-979, 2015.

A. Bast and G. Haenen, Ten misconceptions about antioxidants, Trends Pharmacol Sci, vol.34, issue.8, pp.430-436, 2013.

A. R. Mendelsohn and J. W. Larrick, Paradoxical effects of antioxidants on cancer, Rejuvenation Res, vol.17, issue.3, pp.306-311, 2014.

J. Wang and Y. J. , Cancer cell killing via ROS: to increase or decrease, that is the question, Cancer Biol Ther, vol.7, issue.12, pp.1875-1884, 2008.